Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
ViroMissile, Inc.
SystImmune Inc.
AccSalus Biosciences, Inc.
National Cancer Institute (NCI)
Provectus Pharmaceuticals
Eli Lilly and Company
INSYS Therapeutics Inc
European Organisation for Research and Treatment of Cancer - EORTC